Cytek Biosciences Inc (CTKB)
Working capital turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 193,014 | 183,117 | 175,594 | 166,060 | 164,036 | 155,086 | 148,985 | 139,234 | |||
Total current assets | US$ in thousands | 392,060 | 422,315 | 424,821 | 425,622 | 454,020 | 443,859 | 443,270 | 439,112 | 431,733 | 439,826 | 216,938 |
Total current liabilities | US$ in thousands | 56,226 | 58,693 | 53,591 | 56,517 | 49,040 | 41,494 | 42,350 | 42,803 | 33,181 | 30,014 | 28,165 |
Working capital turnover | 0.57 | 0.50 | 0.47 | 0.45 | 0.41 | 0.39 | 0.37 | 0.35 |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $193,014K ÷ ($392,060K – $56,226K)
= 0.57
Working capital turnover measures how efficiently a company is utilizing its working capital to generate sales revenue. A higher turnover ratio indicates that the company is effectively using its working capital to support sales.
Looking at the data provided for Cytek Biosciences Inc, we can see a gradual improvement in the working capital turnover ratio over the last few quarters. The ratio has increased from 0.35 in Q1 2021 to 0.57 in Q4 2023. This suggests that the company has been able to generate more sales revenue relative to its working capital in recent quarters.
The upward trend in the working capital turnover ratio may indicate that Cytek Biosciences Inc is managing its working capital more efficiently, possibly through effective inventory management, accounts receivable collection, and accounts payable management. This improved efficiency can result in a better cash flow position and stronger liquidity for the company.
Overall, the increasing trend in Cytek Biosciences Inc's working capital turnover ratio indicates positive developments in the company's working capital management and operational efficiency. It suggests that the company is using its resources more effectively to generate sales revenue, which can be a favorable sign for investors and stakeholders.
Peer comparison
Dec 31, 2023